MedPath

Effect of supplementation in treatment of patients with diabetic nephropathy

Phase 3
Conditions
Diabetic nephropathy.
Glomerular disorders in diabetes mellitus (E10-E14 with common fourth character .2+)
N08.3
Registration Number
IRCT201606205623N85
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with diabetic nephropathy
Aged 40 to 85 years

Exclusion Criteria

Alterations in antidiabetic medication doses during the study
Consumption of any nutritional supplements within 3 months
Subjects with uncontrolled diabetes
Pregnant women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath